Zevra Therapeutics (ZVRA) Tax Rate Growth (5y) (2019 - 2025)

Zevra Therapeutics (ZVRA) Tax Rate Growth (5y) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,831.58 Bn 66,831.30 Bn -
2 Nanobiotix 1,916.61 Bn 1,916.55 Bn -
3 Akari Therapeutics 976.78 Bn 976.78 Bn -
4 BeOne Medicines 471.48 Bn 466.69 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.78 Bn 114.53 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn
7 Belite Bio 63.06 Bn 63.06 Bn -
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.54 Bn 34.53 Bn 959.66 Mn
10 Zevra Therapeutics 563.91 Mn 363.29 Mn 34.32 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 4,320.00
Dec 31, 2024 -7,560.00
Jun 30, 2024 -45.00
Mar 31, 2024 35.00
Sep 30, 2023 -213.00
Jun 30, 2023 241.00
Mar 31, 2023 74.00
Dec 31, 2022 84.00
Jun 30, 2022 -23.00
Mar 31, 2022 -6.00
Dec 31, 2021 -131.00
Sep 30, 2020 132.00
Dec 31, 2019 36.00
Sep 30, 2019 -43.00
Jun 30, 2019 -7.00
Mar 31, 2019 -20.00